A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
Completed · Phase 2 · Has a placebo group
Conditions studied: Dental Pain
In brief
This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain either perioperatively or postoperatively in a third molar extraction pain model, and to further evaluate the drug's safety. Approximately 150 subjects from the US will be enrolled in this study.
Key facts
- Study ID
- NCT00542035
- Run by
- Pfizer
- People needed
- 103
- Starts
- 2007-11-11
- Expected to finish
- 2008-02-11
- Last updated by the study team
- 2021-02-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- SCIREX Research Center — San Marcos, Texas, United States
- SCIREX Research Center — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.